Home / Pharmaceuticals / Global High Throughput Process Development Market By Product (Consumables and Reagents and Instruments), By Process (Upstream and Downstream), By Molecule Type (Monoclonal Antibodies, Vaccines, Recombinant Insulin, Human Growth Hormones and Others) - Growth, Future Prospects & Competitive Analysis, 2017 - 2025

Global High Throughput Process Development Market By Product (Consumables and Reagents and Instruments), By Process (Upstream and Downstream), By Molecule Type (Monoclonal Antibodies, Vaccines, Recombinant Insulin, Human Growth Hormones and Others) - Growth, Future Prospects & Competitive Analysis, 2017 - 2025

Published: Oct 2017 | Report Code: 58745-10-17

For the purpose of this study, the various products studied includes consumables and reagents, and instruments. The process are classified as upstream and downstream.

Based on molecule type, this market is further segmented as monoclonal antibodies, vaccines, recombinant insulin, human growth hormones and others. Market size estimates and forecast of these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

The geographic segmentation of the global high throughput process development market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The regions are also further sub-segmented on the basis of major countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global high throughput process development market. Market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global high throughput process development market. The major players in high throughput process development market are Agilent Technologies, Inc., Axxam S.P.A., Aurora Biomed, Bio-Rad Laboratories, Inc., Danaher Corporation, Hamilton Company, Merck Millipore Corporation, Perkin Elmer, Inc., Tecan Group Ltd., Thermo Fisher Scientific, Inc.

High Throughput Process Development Market

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global High Throughput Process Development Market Portraiture
2.1.1. Global High Throughput Process Development Market, by Product, 2016
2.1.2. Global High Throughput Process Development Market, by Process, 2016
2.1.3. Global High Throughput Process Development Market, by Molecule Type, 2016
2.1.4. Global High Throughput Process Development Market, by Geography, 2016

Chapter 3. High Throughput Process Development: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global High Throughput Process Development Market, by Product
4.3. Consumables and Reagents
4.4. Instruments

Chapter 5. Global High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Upstream
5.3. Downstream

Chapter 6. Global High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. Monoclonal Antibodies
6.3. Vaccines
6.4. Recombinant Insulin
6.5. Human Growth Hormones
6.6. Others

Chapter 7. Global High Throughput Process Development Market, by Geography, 2015 – 2025 (US$ Mn)
7.1. Overview
7.2. North America High Throughput Process Development Market Analysis, 2015 – 2025
7.2.1. North America High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
7.2.2. North America High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
7.2.3. North America High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
7.2.4. North America High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe High Throughput Process Development Market Analysis, 2015 – 2025
7.3.1. Europe High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
7.3.2. Europe High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
7.3.3. Europe High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
7.3.4. Europe High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific High Throughput Process Development Market Analysis, 2015 – 2025
7.4.1. Asia Pacific High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
7.4.3. Asia Pacific High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
7.4.4. Asia Pacific High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. India
7.4.4.4. Rest of APAC
7.5. Latin America High Throughput Process Development Market Analysis, 2015 – 2025
7.5.1. Latin America High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
7.5.2. Latin America High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
7.5.3. Latin America High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
7.5.4. Latin America High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) High Throughput Process Development Market Analysis, 2015 – 2025
7.6.1. MEA High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
7.6.2. MEA High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
7.6.3. MEA High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
7.6.4. MEA High Throughput Process Development Market, by Region, 2015 – 2025 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Agilent Technologies, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Axxam S.P.A.
8.3. Aurora Biomed
8.4. Bio-Rad Laboratories, Inc.
8.5. Danaher Corporation
8.6. Hamilton Company
8.7. Merck Millipore Corporation
8.8. Perkin Elmer, Inc.
8.9. Tecan Group Ltd.
8.10. Thermo Fisher Scientific, Inc.

List of Tables

TABLE 1 Global High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 2 Global High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
TABLE 3 Global High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
TABLE 4 Global High Throughput Process Development Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 5 North America High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 6 North America High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
TABLE 7 North America High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
TABLE 8 North America High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 10 Europe High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
TABLE 11 Europe High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
TABLE 12 Europe High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
TABLE 19 Latin America High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
TABLE 20 Latin America High Throughput Process Development Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East and Africa High Throughput Process Development Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 22 Middle East and Africa High Throughput Process Development Market, by Process, 2015 – 2025 (US$ Mn)
TABLE 23 Middle East and Africa High Throughput Process Development Market, by Molecule Type, 2015 – 2025 (US$ Mn)
TABLE 24 Middle East and Africa High Throughput Process Development Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 25 Agilent Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Axxam S.P.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Aurora Biomed: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Danaher Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Hamilton Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Merck Millipore Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Perkin Elmer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 Tecan Group Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

List of Figures

FIG. 1 High Throughput Process Development: Market Segmentation
FIG. 2 Global High Throughput Process Development Market Share, by Product, 2016 (Value %)
FIG. 3 Global High Throughput Process Development Market Share, by Process, 2016 (Value %)
FIG. 4 Global High Throughput Process Development Market Share, by Molecule Type, 2016 (Value %)
FIG. 5 Global High Throughput Process Development Market Share, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition, by Geography
FIG. 7 Market Competition Landscape, by Key Players, 2016
FIG. 8 Global High Throughput Process Development Consumables and Reagents Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global High Throughput Process Development Instruments Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Upstream High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Downstream High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Monoclonal Antibodies Market for High Throughput Process Development, 2015 – 2025 (US$ Mn)
FIG. 13 Global Vaccines Market for High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Recombinant Insulin Market for High Throughput Process Development, 2015 – 2025 (US$ Mn)
FIG. 15 Global Human Growth Hormone Market for High Throughput Process Development, 2015 – 2025 (US$ Mn)
FIG. 16 Global Other Molecule Types Market for High Throughput Process Development, 2015 – 2025 (US$ Mn)
FIG. 17 U.S. High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 18 Canada High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 19 U.K. High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 20 Germany High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 21 Rest of Europe High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 22 Japan High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 23 China High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 24 India High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest of Asia Pacific High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 26 Brazil High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 27 Mexico High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 28 Rest of Latin America High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 29 GCC High Throughput Process Development Market, 2015 – 2025 (US$ Mn)
FIG. 30 Rest of Middle East and Africa High Throughput Process Development Market, 2015 – 2025 (US$ Mn)

Based on molecule type, the global high throughput process development market is categorized into

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Insulin
  • Human Growth Hormone
  • Others

High Throughput Process Development Market

High throughput process development is of prime importance as there is tantamount requirement of a robust, reproducible manufacturing process in the life science industries as it is a critical pathway for the development of novel therapies. In order to meet regulatory requirements and technical challenges, a very good understanding of the critical processes and multiparameters involved in high throughput process development is mandatory. In 2016, monoclonal antibodies segment dominated the market mainly due to factors such as rising adoption of targeted immunotherapy, they are highly reproducible, scalable and unlimited production source and hybridomas serve as an immortal source for the production of monoclonal antibodies. The limitations of monoclonal antibodies is that the system is well developed for only mouse and rat models and not for other animals and the USFDA stipulates that monoclonal antibodies are intended for human purpose should be totally free from pathogens including viruses. The vaccines segment is anticipated to register faster growth throughout the forecast period 2017-2025, majorly due to rising incidence of contagious diseases spread by vectors such as parasities, bacteria and virus and they are helpful in preventing the greater cost incurred during the treatment of infectious disease.

Based on process types, the global high throughput process development market is categorized into

  • Upstream
  • Downstream

High Throughput Process Development Market

In the current regulatory scenario, it often takes around a decade and huge amount of money to promote a drug candidate from the development process to the shelves. There is a strong impetus for pursuing methodologies, which can shorten this gap in the process development and manufacturing. In 2016, upstream segment held the largest market share chiefly due to factors such as technological advancement in the production and development of biological drugs has built a strong impetus from novel bio therapeutics clinical trials, optimization of growth kinetics for the enhanced product development and improvement in the inoculum by genetic engineering.

Downstream will be the fastest growing segment throughout the forecast period 2017-2025. Factors supporting the growth of this segment include technological advancement in the separation of biomass from the fermented broth by the centrifugation and ultracentrifugation techniques and stringent regulatory guidelines stipulated by the USFDA, making it extremely important for effective purification of active metabolites as there have been several incidents reported regarding biological drugs related serious adverse events.

Based on product types, the global high throughput process development market is categorized into

  • Consumables and Reagents
  • Instruments

 

High Throughput Process Development Market


The high throughput process development market is driven by factors such as rising prevalence of chronic diseases, aging population and burgeoning requirement for launch of novel drugs to counteract the multiple drug resistance bacterial infection. In addition, increasing number of diagnostic centers and growing physician awareness regarding disease etiology will propel the market penetration for high throughput screening. In 2016, instruments segment held the largest market share chiefly due to factors such as technological advancement in automation techniques and huge application in biopharmaceuticals, contract research organizations, and research institutes etc.

Consumables and reagents will be the fastest growing segment throughout the forecast period 2017-2025 majorly due to factors such as rising prevalence of chronic diseases, steadily increasing diagnostic centers and public private partnership to combat life threatening diseases by setting research and development centers. The major players in high throughput screening market are Agilent Technologies, Inc., Axxam S.P.A., Aurora Biomed, Bio-Rad Laboratories, Inc., Danaher Corporation, Hamilton Company, Merck Millipore Corporation, Perkin Elmer, Inc., Tecan Group Ltd., Thermo Fisher Scientific, Inc.

For the purpose of this study, the global high throughput process development market is categorized into the following regional and country specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

High Throughput Process Development Market 

North America was observed to be the largest market for high throughput process development in the base year 2016. The dominance of North America is mainly attributed to the presence of major giants in biotechnology and pharmaceutical industries focusing on novel drug discovery of biological drug candidates, and existence of advanced healthcare and research facilities. The market growth in Europe is mainly attributed to the increasing number of patients suffering with chronic diseases. This factor boosts the demand for lowering the manufacturing cost of biological drugs and reducing the product development timelines. Asia Pacific was observed as the fastest growing regional segment throughout the forecast period 2017-2025. Factors that are anticipated to propel the market growth in Asia Pacific are presence of large patient pool which can be enrolled to study the safety and efficacy studies for biological drug candidates during clinical trials and enhanced research and development spending by the governmental organizations. Moreover, factors such as developing healthcare infrastructure, and public private partnership between major biopharmaceutical players and academic research institutes are going to fuel the rapid growth of high throughput process development market in Latin America, and Middle East and Africa in the near future.   

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients